Number of new drugs picks up in Europe and U.S.
LONDON (Reuters) - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs...
Home > Reviews
All Stories
Number of new drugs picks up in Europe and U.S.
LONDON (Reuters) - The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs...
Lundbeck’s alcohol dependency drug wins EU green light
LONDON (Reuters) - A novel drug to fight alcohol dependency was given a green light by European regulators on Friday, providing a boost to Danish drugmaker Lundbeck at a time...
Lundbeck’s alcohol dependency drug wins EU green light
LONDON (Reuters) - A novel drug to fight alcohol dependency was given a green light by European regulators on Friday, providing a boost to Danish drugmaker Lundbeck at a time...
J&J says it won’t enforce AIDS drug patent in Africa
LONDON (Reuters) - Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson's HIV/AIDS drug Prezista for sale in Africa and other poor...
J&J says it won’t enforce AIDS drug patent in Africa
LONDON (Reuters) - Generic manufacturers are to be given a free rein to make cheap copies of Johnson & Johnson's HIV/AIDS drug Prezista for sale in Africa and other poor...
GSK and J&J lead rivals in drug access for poor
LONDON (Reuters) - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being...
GSK and J&J lead rivals in drug access for poor
LONDON (Reuters) - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being...
Roche, under fire, offers compromise in flu drug fight
LONDON (Reuters) - Roche has offered an olive branch to scientific critics in a bid to end a bitter fight over blockbuster flu drug Tamiflu that has led to calls...
Roche, under fire, offers compromise in flu drug fight
LONDON (Reuters) - Roche has offered an olive branch to scientific critics in a bid to end a bitter fight over blockbuster flu drug Tamiflu that has led to calls...